Published in Surgery Litigation and Law Weekly, June 1st, 2007
This trend article about University of Munich, Germany, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "Antithrombin and hypercoagulability in sepsis: insights from thrombelastography," is newly published data in Critical Care. According to recent research published in the journal Critical Care, "Antithrombin (AT) has been used for over 25 years to successfully treat disseminated intravascular coagulation (DIC). A four-day AT therapy in patients with DIC in the KyberSept trial has been related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly